Paradigm Biopharmaceuticals (ASX:PAR)
ASX announcement history & article coverage
Transparent by design.
Announcments by Paradigm Biopharmaceuticals (ASX:PAR) are listed here, whether we covered it or not. Where we've written an article, you'll see it linked directly. Where we haven't, the filing is still shown so nothing is hidden from view. If you think a particular announcement deserved editorial coverage and was overlooked, you can flag it for review and our team will take a look.
Appendix 4G and Corporate Governance Statement
Appendix 4E and 2026 Annual Report
Paradigm completes Phase 3 recruitment, raises A$21.74m, reports $56.3m loss, eyes key clinical milestones
Application for quotation of securities - PAR
80% Safety Review Complete, September IA on Track
Application for quotation of securities - PAR
June 2026 Quarterly Activities Report & Appendix 4C
Paradigm completes Phase 3 enrolment, raises A$21.38 million, targets Interim Analysis in September 2026
Notification of cessation of securities - PAR
Paradigm Receives $5.75m R&D Tax Incentive Refund
Paradigm secures $5.75 million in Australian Government R&D tax refunds to support Phase 3 osteoarthritis program
Application for quotation of securities - PAR
Notice under Section 708A
Notification regarding unquoted securities - PAR
Drawdown of Tranche 4 under the Convertible Note Facility
Paradigm Biopharma completes US$3 million drawdown under Convertible Note Facility to support Phase 3 trial
Change of Director's Interest Notice
Notification of cessation of securities - PAR
Notification of cessation of securities - PAR
Change of Director's Interest Notice
Change of Director's Interest Notice
Application for quotation of securities - PAR
Listing of Options - Top 20 Holders and Distribution Reports
Application for quotation of securities - PAR
PAR Completes Enrolment in Pivotal Phase 3
Paradigm completes enrolment in Phase 3 osteoarthritis trial, on track for 2027 results
Options Prospectus
Results of Meeting
Change of Director's Interest Notice
Change of Director's Interest Notice
Ceasing to be a substantial holder
Notification of cessation of securities - PAR
Application for quotation of securities - PAR
Application for quotation of securities - PAR